Press Release

PhRMA Statement on 21st Century Cures Discussion Draft

PhRMA January 27, 2015

Washington, D.C. (January 27, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and Chief Executive Officer John J. Castellani issued the following statement on the newly released 21st Century Cures discussion draft: 

"We appreciate the opportunity to review the discussion draft released today and look forward to providing feedback to the House Energy and Commerce Committee.

 “PhRMA supports the Committee’s goal of accelerating the discovery, development and delivery of new medicines for patients and provided feedback on several of the 21st Century Cures whitepapers.”

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone. 

Find PhRMA Online: 

Website –

Facebook –

Blog –

Twitter –

YouTube –

For information on how innovative medicines save lives, visit:

For information on access to medicines, visit:

For information on the Partnership for Prescription Assistance, visit:

For information on ensuring the flow of medicines during public health emergencies, visit